Tag Archives: Raptor pharmaceutical

September, 2016

• 12 September

  Horizon to Acquire Rare Disease Company Raptor Pharmaceutical for $800 Million

  

  DUBLIN, Ireland and NOVATO, Calif., Sept. 12, 2016 (GLOBE NEWSWIRE) — Horizon Pharma plc (NASDAQ:HZNP) and Raptor Pharmaceutical Corp. (NASDAQ:RPTP) today announced the companies have entered into a definitive agreement under which Horizon Pharma will acquire all of the issued and outstanding shares of Raptor Pharmaceutical Corp. common stock for …

  Share

  • Facebook
  • Twitter
  • LinkedIn

August, 2015

• 21 August

  Raptor Acquires Cystic Fibrosis Drug in $418 Million Deal

  

  NOVATO, Calif., Aug. 20, 2015 (GLOBE NEWSWIRE) — Raptor Pharmaceutical Corp. (Nasdaq:RPTP) announced today that it has signed a definitive agreement with Tripex Pharmaceuticals to acquire Quinsair, the first inhaled fluoroquinolone approved for the management of chronic pulmonary infections due to Pseudomonas aeruginosa in adults with cystic fibrosis, expanding its …

  Share

  • Facebook
  • Twitter
  • LinkedIn